We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow
% of AUM
104.07%
Top 10 Holdings %
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$12.4B |
| 3 |
NVIDIA
NVDA
|
+$9.74B |
| 4 |
Apple
AAPL
|
+$8.35B |
| 5 |
Microsoft
MSFT
|
+$6.8B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.86% |
| 2 | Financials | 11.48% |
| 3 | Communication Services | 7.14% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Healthcare | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Dare Bioscience
DARE
$13.9M
| $5.35K | ﹤0.01% |
+2,940
| New | +$5.03K |
|
3552
SIFCO Industries
SIF
$125M
| $5.32K | ﹤0.01% |
+400
| New | +$4.06K |
|
3553
Brilliant Earth
BRLT
$22.5M
| $5.23K | ﹤0.01% |
+3,930
| New | +$5.92K |
|
3554
Lisata Therapeutics
LSTA
$9.82M
| $5.17K | ﹤0.01% |
+1,033
| New | +$4.26K |
|
3555
INmune Bio
INMB
$60.2M
| $5.13K | ﹤0.01% |
+4,539
| New | +$6.47K |
|
|
DFNS
3556
T3 Defense Inc
DFNS
$34.1M
| $5.09K | ﹤0.01% |
+57
| New | +$15.4K |
|
3557
Passage Bio
PASG
$14.8M
| $5.01K | ﹤0.01% |
+638
| New | +$6.6K |
|
3558
LanzaTech
LNZA
$83M
| $4.93K | ﹤0.01% |
+308
| New | +$3.95K |
|
|
TBHC
3559
DELISTED
The Brand House Collective
TBHC
| $4.88K | ﹤0.01% |
+5,244
| New | +$5.79K |
|
|
UHG
3560
DELISTED
United Homes Group
UHG
| $4.87K | ﹤0.01% |
+4,200
| New | +$6.76K |
|
3561
American Realty Investors
ARL
$242M
| $4.85K | ﹤0.01% |
+314
| New | +$5.22K |
|
3562
Astrotech Corp
ASTC
$16.9M
| $4.76K | ﹤0.01% |
+911
| New | +$2.77K |
|
3563
flyExclusive
FLYX
$129M
| $4.75K | ﹤0.01% |
+2,103
| New | +$6.08K |
|
3564
Beam Global
BEEM
$25.1M
| $4.74K | ﹤0.01% |
+3,226
| New | +$5.08K |
|
3565
Verrica Pharmaceuticals
VRCA
$85.4M
| $4.56K | ﹤0.01% |
+862
| New | +$5.52K |
|
3566
Usio Inc
USIO
$78.6M
| $4.45K | ﹤0.01% |
+3,902
| New | +$5.11K |
|
3567
Reading International Class A
RDI
$36.6M
| $4.42K | ﹤0.01% |
+3,911
| New | +$4.25K |
|
3568
Grove Collaborative
GROV
$44M
| $4.37K | ﹤0.01% |
+3,413
| New | +$4.65K |
|
3569
Harte-Hanks
HHS
$31.9M
| $4.35K | ﹤0.01% |
+1,918
| New | +$5.44K |
|
3570
LivePerson
LPSN
$35.2M
| $4.35K | ﹤0.01% |
+1,706
| New | +$5.19K |
|
3571
Southland Holdings
SLND
$32.1M
| $4.34K | ﹤0.01% |
+3,338
| New | +$5.98K |
|
3572
Milestone Scientific
MLSS
$43.9M
| $4.28K | ﹤0.01% |
+14,867
| New | +$4.15K |
|
|
MPTI.RT
3573
DELISTED
M-tron Industries Rights (expiring April 15 2026)
MPTI.RT
| $4.24K | ﹤0.01% |
+2,017
| New | +$4.24K |
|
|
KLRS
3574
Kalaris Therapeutics
KLRS
$97.1M
| $4.18K | ﹤0.01% |
+725
| New | +$6.43K |
|
3575
IRIDEX
IRIX
$14.9M
| $4K | ﹤0.01% |
+3,963
| New | +$5.41K |
|
Similar funds
Vanguard Global Advisers's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Communication Services.
- Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
- Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.